<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Uterine artery embolization for symptomatic uterine fibroids - Gupta, JK - 2014 | Cochrane Library</title> <meta content="Uterine artery embolization for symptomatic uterine fibroids - Gupta, JK - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005073.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Uterine artery embolization for symptomatic uterine fibroids - Gupta, JK - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005073.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005073.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Uterine artery embolization for symptomatic uterine fibroids" name="citation_title"/> <meta content="Janesh K Gupta" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="j.k.gupta@bham.ac.uk" name="citation_author_email"/> <meta content="Anju Sinha" name="citation_author"/> <meta content="University Hospital of Wales" name="citation_author_institution"/> <meta content="M A Lumsden" name="citation_author"/> <meta content="University of Glasgow" name="citation_author_institution"/> <meta content="Martha Hickey" name="citation_author"/> <meta content="The Royal Women's Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD005073.pub4" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/12/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005073.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005073.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005073.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Embolization, Therapeutic [methods]; Hysterectomy; Leiomyoma [blood supply, *therapy]; Length of Stay; Patient Satisfaction; Randomized Controlled Trials as Topic; Uterine Artery Embolization [adverse effects, *methods]; Uterine Neoplasms [blood supply, *therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005073.pub4&amp;doi=10.1002/14651858.CD005073.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="6nHUP32m";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005073\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005073\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005073.pub4",title:"Uterine artery embolization for symptomatic uterine fibroids",firstPublishedDate:"Dec 26, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005073.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005073.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005073.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005073.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005073.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005073.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005073.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005073.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005073.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005073.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8899 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005073.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0101"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/appendices#CD005073-sec-0106"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/table_n/CD005073StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/table_n/CD005073StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Uterine artery embolization for symptomatic uterine fibroids</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#CD005073-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Janesh K Gupta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#CD005073-cr-0003">Anju Sinha</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#CD005073-cr-0004">M A Lumsden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information#CD005073-cr-0005">Martha Hickey</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information/en#CD005073-sec-0117">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 December 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005073.pub4">https://doi.org/10.1002/14651858.CD005073.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005073-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005073-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005073-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005073-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005073-abs-0001" lang="en"> <section id="CD005073-sec-0001"> <h3 class="title" id="CD005073-sec-0001">Background</h3> <p>Uterine fibroids cause heavy prolonged bleeding, pain, pressure symptoms and subfertility. The traditional method of treatment has been surgery as medical therapies have not proven effective. Uterine artery embolization has been reported to be an effective and safe alternative to treat fibroids in women not desiring future fertility. There is a significant body of evidence that is based on case controlled studies and case reports. This is an update of the review previously published in 2012. </p> </section> <section id="CD005073-sec-0002"> <h3 class="title" id="CD005073-sec-0002">Objectives</h3> <p>To review the benefits and risks of uterine artery embolization (UAE) versus other medical or surgical interventions for symptomatic uterine fibroids. </p> </section> <section id="CD005073-sec-0003"> <h3 class="title" id="CD005073-sec-0003">Search methods</h3> <p>We searched sources including the Cochrane Menstrual Disorders and Subfertility Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and trial registries. The search was last conducted in April 2014. We contacted authors of eligible randomised controlled trials to request unpublished data. </p> </section> <section id="CD005073-sec-0004"> <h3 class="title" id="CD005073-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of UAE versus any medical or surgical therapy for symptomatic uterine fibroids. The primary outcomes of the review were patient satisfaction and live birth rate (among women seeking live birth). </p> </section> <section id="CD005073-sec-0005"> <h3 class="title" id="CD005073-sec-0005">Data collection and analysis</h3> <p>Two of the authors (AS and JKG) independently selected studies, assessed quality and extracted data. Evidence quality was assessed using GRADE methods. </p> </section> <section id="CD005073-sec-0006"> <h3 class="title" id="CD005073-sec-0006">Main results</h3> <p>Seven RCTs with 793 women were included in this review. Three trials compared UAE with abdominal hysterectomy, two trials compared UAE with myomectomy, and two trials compared UAE with either type of surgery (53 hysterectomies and 62 myomectomies). </p> <p>With regard to patient satisfaction rates, our findings were consistent with satisfaction rates being up to 41% lower or up to 48% higher with UAE compared to surgery within 24 months of having the procedure (odds ratio (OR) 0.94; 95% confidence interval (CI) 0.59 to 1.48, 6 trials, 640 women, I<sup>2</sup> = 5%, moderate quality evidence). Findings were also inconclusive at five years of follow‐up (OR 0.90; 95% CI 0.45 to 1.80, 2 trials, 295 women, I<sup>2</sup> = 0%, moderate quality evidence). There was some indication that UAE may be associated with less favourable fertility outcomes than myomectomy, but it was very low quality evidence from a subgroup of a single study and should be regarded with extreme caution (live birth: OR 0.26; 95% CI 0.08 to 0.84; pregnancy: OR 0.29; 95% CI 0.10 to 0.85, 1 study, 66 women). </p> <p>Similarly, for several safety outcomes our findings showed evidence of a substantially higher risk of adverse events in either arm or of no difference between the groups. This applied to intra‐procedural complications (OR 0.91; 95% CI 0.42 to 1.97, 4 trials, 452 women, I<sup>2</sup> = 40%, low quality evidence), major complications within one year (OR 0.65; 95% CI 0.33 to 1.26, 5 trials, 611 women, I<sup>2</sup> = 4%, moderate quality evidence) and major complications within five years (OR 0.56; CI 0.27 to 1.18, 2 trials, 268 women). However, the rate of minor complications within one year was higher in the UAE group (OR 1.99; CI 1.41 to 2.81, 6 trials, 735 women, I<sup>2</sup> = 0%, moderate quality evidence) and two trials found a higher minor complication rate in the UAE group at up to five years (OR 2.93; CI 1.73 to 4.93, 2 trials, 268 women). </p> <p>UAE was associated with a higher rate of further surgical interventions (re‐interventions within 2 years: OR 3.72; 95% CI 2.28 to 6.04, 6 trials, 732 women, I<sup>2</sup> = 45%, moderate quality evidence; within 5 years: OR 5.79; 95% CI 2.65 to 12.65, 2 trials, 289 women, I<sup>2</sup> = 65%). If we assumed that 7% of women will require further surgery within two years of hysterectomy or myomectomy, between 15% and 32% will require further surgery within two years of UAE. </p> <p>The evidence suggested that women in the UAE group were less likely to require a blood transfusion than women receiving surgery (OR 0.07; 95% CI 0.01 to 0.52, 2 trials, 277 women, I<sup>2</sup> = 0%). UAE was also associated with a shorter procedural time (two studies), shorter length of hospital stay (seven studies) and faster resumption of usual activities (six studies) in all studies that measured these outcomes; however, most of these data could not be pooled due to heterogeneity between the studies. </p> <p>The quality of the evidence varied, and was very low for live birth, moderate for satisfaction ratings, and moderate for most safety outcomes. The main limitations in the evidence were serious imprecision due to wide confidence intervals, failure to clearly report methods, and lack of blinding for subjective outcomes. </p> </section> <section id="CD005073-sec-0007"> <h3 class="title" id="CD005073-sec-0007">Authors' conclusions</h3> <p>When we compared patient satisfaction rates at up to two years following UAE versus surgery (myomectomy or hysterectomy) our findings are that there is no evidence of a difference between the interventions. Findings at five year follow‐up were similarly inconclusive. There was very low quality evidence to suggest that myomectomy may be associated with better fertility outcomes than UAE, but this information was only available from a selected subgroup in one small trial. </p> <p>We found no clear evidence of a difference between UAE and surgery in the risk of major complications, but UAE was associated with a higher rate of minor complications and an increased likelihood of requiring surgical intervention within two to five years of the initial procedure. If we assume that 7% of women will require further surgery within two years of hysterectomy or myomectomy, between 15% and 32% will require further surgery within two years of UAE. This increase in the surgical re‐intervention rate may balance out any initial cost advantage of UAE. Thus although UAE is a safe, minimally invasive alternative to surgery, patient selection and counselling are paramount due to the much higher risk of requiring further surgical intervention. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005073-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005073-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005073-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005073-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005073-abs-0003">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005073-abs-0002" lang="en"> <h3>Uterine artery embolization for symptomatic uterine fibroids</h3> <p><b>Review question</b> </p> <p>Is uterine artery embolization a safe and effective alternative treatment in women with symptomatic fibroids? </p> <p><b>Background</b> </p> <p>Uterine fibroids (benign tumours) can cause varied symptoms such as heavy bleeding, pain and reduced likelihood of pregnancy. Surgery (hysterectomy or myomectomy) has traditionally been the main treatment option but it carries a risk of complications. Uterine artery embolization (UAE) is a newer treatment option which blocks the blood supply to the womb and thus shrinks the fibroids and reduces their effects. The evidence was current to April 2014. </p> <p><b>Study characteristics</b> </p> <p>There were seven studies included in the review (793 participants). Three of these compared UAE with hysterectomy, two studies compared UAE with myomectomy, and another two with hysterectomy or myomectomy. The studies differed in their outcomes and length of follow‐up. </p> <p><b>Key results</b> </p> <p>With regard to patient satisfaction rates, our findings were consistent with satisfaction rates being up to 41% lower or up to 48% higher with UAE compared to surgery within 24 months of having the procedure. Findings on satisfaction rates were also inconclusive at five years of follow‐up. </p> <p>There was very low quality evidence to suggest that fertility outcomes (live birth and pregnancy) may be better after myomectomy than after UAE, but this evidence was based on a small selected subgroup and should be regarded with extreme caution. The UAE group had a shorter hospital stay and a more rapid return to daily activities. With regards to safety, the evidence on major complications was inconclusive and consistent with benefit or harm, or no difference, from either intervention. However, the risk of minor complications was higher after UAE. Moreover, there was a higher likelihood of needing another surgical intervention after UAE, at two year and at five year follow‐up. If we assumed that 7% of women will require further surgery within two years of hysterectomy or myomectomy, between 15% and 32% will require further surgery within two years of UAE. Therefore, it appears that while UAE is a safe option with an earlier initial recovery, it does carry a higher risk of minor complications and the need for further surgery later on. </p> <p><b>Quality of the evidence:</b> </p> <p>The quality of the evidence varied from very low for live birth, to moderate for satisfaction ratings and for most safety outcomes. The main limitations in the evidence were serious imprecision, failure to clearly report methods, and lack of blinding for subjective outcomes. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005073-sec-0101" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005073-sec-0101"></div> <h3 class="title" id="CD005073-sec-0102">Implications for practice</h3> <section id="CD005073-sec-0102"> <p>When we compared patient satisfaction rates at up to two years following UAE versus surgery (myomectomy or hysterectomy), our findings were evidence of substantial benefit or harm from either intervention, or of no difference between them. Findings at five year follow‐up were similarly inconclusive. There was very low quality evidence to suggest that myomectomy may be associated with better fertility outcomes than UAE, but this information was only available from a selected subgroup in one small trial and should be regarded with extreme caution. </p> <p>We found no clear indication of a difference between UAE and surgery in the risk of major complications, but UAE was associated with a higher rate of minor complications and an increased likelihood of requiring surgical intervention within two to five years of the initial procedure. If we assume that 7% of women will require further surgery within two years of hysterectomy or myomectomy, between 15% and 32% will require further surgery within two years of UAE. This increase in the surgical re‐intervention rate may balance out any initial cost advantage of UAE. Thus although UAE is a safe, minimally invasive alternative to surgery, patient selection and counselling is paramount due to the much higher risk of requiring further surgical intervention. </p> </section> <h3 class="title" id="CD005073-sec-0103">Implications for research</h3> <section id="CD005073-sec-0103"> <p>Although we have some long term follow‐up studies comparing UAE with hysterectomy, there is a continued need for further larger randomised controlled trials assessing fertility outcomes of UAE in women with symptomatic fibroids, that is by comparing UAE with myomectomy. The FEMME study (UK) is currently ongoing and we await the results. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005073-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005073-sec-0015"></div> <div class="table" id="CD005073-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Uterine artery embolization (UAE) compared to surgery for symptomatic uterine fibroids</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>UAE compared to surgery for symptomatic uterine fibroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women with symptomatic uterine fibroids<br/> <b>Intervention:</b> UAE<br/> <b>Comparison:</b> surgery </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> UAE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with treatment up to 24 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>861 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>853 per 1000<br/> (785 to 901) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.94<br/> (0.59 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>640<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with treatment at 5 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>876 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>864 per 1000<br/> (761 to 927) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.90<br/> (0.45 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>295<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth ‐ UAE versus myomectomy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>475 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1000<br/> (67 to 432) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.26<br/> (0.08 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: intra‐procedural complications</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000<br/> (27 to 117) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.91<br/> (0.42 to 1.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>452<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>5,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: minor post‐procedural complications within one year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>230 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>373 per 1000<br/> (296 to 456) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.99<br/> (1.41 to 2.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>735<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: major post‐procedural complications within one year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000<br/> (24 to 85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.65<br/> (0.33 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>611<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,5,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Further interventions within 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1000<br/> (149 to 317) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 3.72<br/> (2.28 to 6.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>732<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,2,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Studies unblinded </p> <p><sup>2</sup>Two studies did not fully explain randomisation and allocation concealment, but quality not downgraded for this as their omission from analysis did not substantially change the findings </p> <p><sup>3</sup> Wide confidence intervals compatible with substantial harm from UAE or with no effect </p> <p><sup>4</sup>Includes only those trial participants who wished to conceive (66/121) </p> <p><sup>5</sup>One study did not fully explain methods of randomisation and allocation concealment, but omission of this study did not substantially affect the findings </p> <p><sup>6</sup>Low event rate </p> <p><sup>7</sup>Wide confidence intervals compatible with substantial harm or benefit from either intervention, or with no effect </p> <p><sup>8</sup>Some statistical heterogeneity (I<sup>2</sup> = 45%); quality not downgraded for this as direction of effect is consistent </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005073-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005073-sec-0016"></div> <section id="CD005073-sec-0017"> <h3 class="title" id="CD005073-sec-0017">Description of the condition</h3> <p>Uterine fibroids (also called myomas) are the most commonly found gynaecological benign tumours. The precise factors governing their growth and regression are unknown, but fibroids grow in response to stimulation from sex steroid hormones. They are typically discovered in the late reproductive period and are present in up to 60% of women after the age of 40 years (<a href="./references#CD005073-bbs2-0023" title="OkoloS . Incidence, aetiology and epidemiology of uterine fibroids. Best Practice &amp; Research Clinical Obstetrics and Gynaecology2008;22(4):571–88. ">Okolo 2008</a>). Spontaneous regression occurs following menopause, probably as a result of the reduction in estrogen hormone production by the ovaries. </p> <p>Complaints associated with fibroids, particularly heavy menstrual bleeding, affect quality of life and comprise a substantial societal burden, with a significant impact on health care use and costs (<a href="./references#CD005073-bbs2-0011" title="Cardozo ER. Clark AD. Banks NK. Henne MB. Stegmann BJ. SegarsJH . The estimated annual cost of uterine leiomyomata in the United States. American Journal of Obstetrics &amp; Gynecology2012;206(3):211.e1‐9. ">Cardozo 2012</a>). In the UK, one million women annually seek help for heavy menstrual bleeding (<a href="./references#CD005073-bbs2-0022" title="National Institute for Health and Care Excellence. Heavy menstrual bleeding. http://www.nice.org.uk/guidance/cg44 (accessed 22 December 2014). ">NICE 2007</a>) and reported treatment costs exceed £65m; an estimated 3.5 million work‐days are lost annually (<a href="./references#CD005073-bbs2-0026" title="RahnDD , AbedH , SungVW , MattesonKA , RogersRG , MorrillMY , et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol2011;64(3):293‐300. ">Rahn 2011</a>). </p> <p>Fibroids can cause heavy and prolonged uterine bleeding, pain, pressure symptoms and subfertility, but rarely cause damage to adjacent organs. Asymptomatic fibroids can be discovered on routine pelvic examination and verified on ultrasound. Treatment of fibroids is generally reserved for those women who experience symptoms and for women planning to become pregnant who have large fibroids or fibroids that significantly distort the uterine cavity. </p> </section> <section id="CD005073-sec-0018"> <h3 class="title" id="CD005073-sec-0018">Description of the intervention</h3> <p>Currently available medical therapies for fibroids have not demonstrated long‐term efficacy. Gonadotrophin‐releasing hormone analogues effectively reduce bleeding and decrease fibroid size but can only be used for a limited time because of their adverse effect on bone mass. Medical therapies for heavy menstrual bleeding, such as combined oral contraceptives, non‐steroidal anti‐inflammatory drugs and progestogens (including the Mirena intrauterine system), appear to be less effective in the presence of uterine fibroids although few studies have addressed this issue. There is recent evidence that selective progesterone receptor modulators (SPRMs), namely ulipristal acetate, can be used to treat heavy menstrual bleeding in the short term and to reduce total fibroid volume in preparation for surgery (<a href="./references#CD005073-bbs2-0024" title="DonnezJ , TatarchukTF , BouchardP , et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. New England Journal of Medicine2012;366(5):409‐20. ">PEARL I</a>; <a href="./references#CD005073-bbs2-0025" title="DonnezJ , TomaszewskiJ , VázquezF . Ulipristal acetate versus leuprolide acetate for uterine fibroids. New England Journal of Medicine2012;366(5):421‐32. ">PEARL II</a>). Surgical therapies for the treatment of heavy menstrual bleeding related to fibroids include hysteroscopic endometrial ablation, transcervical resection of submucous fibroid, laparoscopic myomectomy or myolysis, laparoscopic bipolar coagulation or dissection of uterine vessels (or both), myomectomy and hysterectomy. </p> <p>It is not uncommon for women with symptomatic fibroids to have surgical treatment, accounting for between 30% to 70% of the approximately 600,000 hysterectomies performed in the US each year (<a href="./references#CD005073-bbs2-0010" title="BroderMS , KanouseDE , MittmanBS , BernsteinSJ . The appropriateness of recommendations for hysterectomy in Southern California. Obstetrics and Gynaecology2000;95(2):199‐205. ">Broder 2000</a>; <a href="./references#CD005073-bbs2-0020" title="LepineLA , HillisSD , MarchbanksPA , KooninLM , MorrowB , KickeBA , et al. Hysterectomy surveillance. United States 1980‐1983. Morbidity and Mortality Weekly Reports1997;46 (SS‐4):1‐16. ">Lepine 1997</a>). Other surgical procedures for fibroids are done less commonly, with approximately 35,000 abdominal or open myomectomies each year (<a href="./references#CD005073-bbs2-0021" title="National Centre for Health Statistics. Ambulatory and Inpatient Procedures in the United States, 1996. Hyattsville, Maryland: Public Health Service 1998; DHSS Publication No (PHS)99‐1710. ">NCHS 1998</a>). As with all surgical procedures, hysterectomy and myomectomy are associated with complications. Hysterectomy has an approximately 3% incidence of major complications (<a href="./references#CD005073-bbs2-0013" title="GarryR , FountainJ , MasonS , HaweJ , NappV , AbbottJ , et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ2004;328(7432):129. ">Garry 2004</a>), while the rate for myomectomy is less well defined. Myomectomy is associated with long‐term problems such as fibroid recurrence, adhesion formation, and the increased possibility of uterine rupture during pregnancy and vaginal delivery (<a href="./references#CD005073-bbs2-0014" title="GehlbachDL , SousaRC , CarpenterSE , RockJA . Abdominal myomectomy in the treatment of infertility. International Journal of Gynaecology and Obstetrics1993;40(1):45‐50. ">Gehlbach 1993</a>). There is a high need for effective non‐surgical therapies for uterine fibroids. </p> <p>Uterine artery embolization (UAE) has established itself as a minimally invasive procedure for reducing symptoms from uterine fibroids. In the past, embolization was used to reduce pelvic pain and bleeding (<a href="./references#CD005073-bbs2-0016" title="GreenwoodC , GlickmanM , SchwartzP , MorseSS , DennyDF . Obstetric and non malignant gynecologic bleeding: Treatment with angiographic embolization radiology. Radiology1987;164(1):155‐9. ">Greenwood 1987</a>). Only since 1995 has UAE been seen as a potential treatment for menorrhagia related to uterine fibroids (<a href="./references#CD005073-bbs2-0015" title="GoodwinS , VendanthamS , McLucasB , FornoA , PerellaR . Preliminary experience with uterine fibroid embolization for uterine fibroids. Journal of Vascular and Interventional Radiology1997;8:517‐26. ">Goodwin 1997</a>; <a href="./references#CD005073-bbs2-0027" title="RavinaJH , BouretJM , Ciraru‐VigneronN , RepiqurtD , HerbreteauD , AymardA , et al. Recourse to particular arterial embolization in the treatment of some uterine leiomyoma. Bulletin de Academie Nationale de Medecine1997;181(2):233‐43. ">Ravina 1997</a>). Promising results have been obtained with regard to symptom relief but there is concern about post‐procedure pain, post‐embolization syndrome, infection, premature ovarian failure (POF), secondary amenorrhoea due to endometrial atrophy or intrauterine adhesions, and the unknown effect on conception and pregnancy (<a href="./references#CD005073-bbs2-0019" title="KhaundA , LumsdenMA . Impact of fibroids on reproductive function. Best Practice &amp; Research Clinical Obstetrics and Gynaecology2008;22(4):749‐56. ">Khaund 2008</a>). </p> <p>UAE, like myomectomy, spares the uterus and carries an obvious appeal to women with large fibroids who are either subfertile or repeatedly miscarry. There are reports of live births following fibroid embolization. Potential complications following the procedure are ovarian failure due to impairment of ovarian blood flow and infection leading to fallopian tube damage with subsequent infertility. There has been a report of uterine rupture at childbirth following UAE. There is also the theoretical risk of an adverse effect on placental blood flow following UAE. In these circumstances, there is the possibility that the incidence of pregnancy complications such as preterm labour, intrauterine growth restriction and postpartum haemorrhage could be increased, and further data are awaited. Hence, the UAE procedure is suitable for women with fibroids who have completed their families and also for those wishing to conceive who have symptomatic fibroids (for example heavy menstrual bleeding) after careful and appropriate counselling. </p> <p>UAE involves complete occlusion of both uterine arteries with particulate emboli, with the objective of causing ischaemic necrosis of the uterine fibroids but no permanent adverse effect on the otherwise normal uterus. This has been performed using general anaesthesia, conscious sedation, and epidural or spinal anaesthesia. Some practitioners administer prophylactic antibiotics. An angiography catheter is inserted directly into the woman's femoral artery and the contralateral uterine artery is then selectively catheterized. The catheter is manoeuvred to the opposite uterine artery (ipsilateral to the femoral puncture site) and the process repeated. The most commonly used agent for occlusion is polyvinyl alcohol (PVA), a non‐biodegradable agent available in a variety of sizes (normally 150 to 1000 microns for this procedure) which is suspended in a contrast solution. Occlusion (blockage) of the uterine vessels is confirmed by angiography (X‐ray dye test) and the catheter removed. The procedure takes between 45 and 135 minutes to complete and the woman is exposed to approximately 20 rads (20 cGy) of ionising radiation to the ovaries (<a href="./references#CD005073-bbs2-0028" title="SpiesJB , WarrenEH , MathiasSD , WalshSM , RothAR , PentecostMJ . Uterine fibroid embolization: measurement of health‐related quality of life before and after therapy. Journal of Vascular and Interventional Radiology1999;10(10):1293‐303. ">Spies 1999</a>). Women are observed for up to 24 hours post‐procedure and treated with narcotics for pain relief. </p> </section> <section id="CD005073-sec-0019"> <h3 class="title" id="CD005073-sec-0019">How the intervention might work</h3> <p>Successful UAE is meant to totally occlude both the uterine vessels. The normal myometrium (muscle of the womb) rapidly establishes a new blood supply through collateral vessels from the ovarian and vaginal circulations. However, fibroids appear to be supplied by end arteries without the collateral flow found in normal myometrium and, therefore, are preferentially affected by the occlusion. The reduction in blood supply results in a decrease in fibroid volume with resultant improvement in the woman's symptoms. </p> </section> <section id="CD005073-sec-0020"> <h3 class="title" id="CD005073-sec-0020">Why it is important to do this review</h3> <p>The UK National Institute for Health and Clinical Excellence (NICE) recommends that UAE should be offered as a treatment choice in women presenting with heavy menstrual bleeding. NICE does not indicate a preference in subfertile women (<a href="./references#CD005073-bbs2-0022" title="National Institute for Health and Care Excellence. Heavy menstrual bleeding. http://www.nice.org.uk/guidance/cg44 (accessed 22 December 2014). ">NICE 2007</a>). However, surgical treatment is often used for symptomatic women with fibroids. This is more true for women who have subfertility due to fibroids. All of the surgical procedures are associated with risks. UAE is being suggested as an alternative but is not without its own risks. Therefore, it is important to have the best available evidence to compare different types of interventions. The current state of the evidence reported in this review highlights the high level of uncertainty within the trials indicating that further high quality trials are required. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005073-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005073-sec-0021"></div> <p>To review the benefits and risks of uterine artery embolization (UAE) versus other medical or surgical interventions for symptomatic uterine fibroids. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005073-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005073-sec-0022"></div> <section id="CD005073-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005073-sec-0024"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) of uterine artery embolization versus other interventions. </p> </section> <section id="CD005073-sec-0025"> <h4 class="title">Types of participants</h4> <p>Women with symptomatic uterine fibroids, with either subjective or objective symptoms (expected to be predominantly heavy menstrual bleeding with or without intermenstrual bleeding, but also including pain and bulk‐related symptoms), or both. </p> </section> <section id="CD005073-sec-0026"> <h4 class="title">Types of interventions</h4> <p>Bilateral UAE using permanent embolic material versus any other surgical intervention as a primary treatment for symptomatic fibroids, for example myomectomy or hysterectomy. UAE was evaluated as a single therapy, not combined with surgery. </p> <p>We excluded trials of the occlusion of uterine arteries by any means other than embolization.</p> </section> <section id="CD005073-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD005073-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD005073-list-0001"> <li> <p>Patient satisfaction (up to 24 months and at five years)</p> </li> <li> <p>Live birth (in comparisons of UAE versus uterine‐sparing procedures only)</p> </li> </ol> </p> </section> <section id="CD005073-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD005073-list-0002"> <li> <p>Adverse events: immediate complications (intra‐procedural complications, need for blood transfusion); early and late post‐procedural complications (minor and major) </p> </li> <li> <p>Further interventions</p> </li> <li> <p>Unscheduled readmission rates</p> </li> <li> <p>Cost (duration of procedure, length of hospital stay, resumption of normal activities)</p> </li> <li> <p>Follicle stimulating hormone (FSH) levels post‐procedure (as an indication of ovarian failure) </p> </li> <li> <p>Fibroid recurrence rate (in comparisons of UAE versus uterine‐sparing procedures only)</p> </li> <li> <p>Pregnancy (in comparisons of UAE versus uterine‐sparing procedures only)</p> </li> <li> <p>Health‐related quality of life</p> </li> </ol> </p> </section> </section> </section> <section id="CD005073-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <p>All eligible studies since the previous version of this review in 2012 were identified by a predefined search strategy that was applied in electronic databases, handsearching, reference lists and contacting authors. </p> <section id="CD005073-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched for all relevant published and unpublished RCTs without language restriction and in consultation with the Menstrual Disorders and Subfertility Group Trials Search Co‐ordinator. </p> <p> <ul id="CD005073-list-0003"> <li> <p>Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (inception to 17 April 2014). </p> </li> <li> <p>Ovid Cochrane Central Register of Controlled Trials (CENTRAL) (inception to 17 April 2014). </p> </li> <li> <p>Ovid MEDLINE(R) In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily Update and Ovid MEDLINE(R) (1950 to 17 April 2014). </p> </li> <li> <p>Ovid EMBASE (1 January 2010 to 17 April 2014). EMBASE was only searched four years back as the UK Cochrane Centre had handsearched EMBASE to this point and these trials are already in CENTRAL.  </p> </li> <li> <p>Ovid PsycINFO (inception to 17 April 2014).</p> </li> <li> <p>EBSCO CINAHL (inception to 17 April 2014).</p> </li> <li> <p>metaRegister of Controlled Trials (http://controlled‐trials.com/mrct/).</p> </li> <li> <p>Trial registers for ongoing and registered trials: ClinicalTrials.gov, a service of the US National Institutes of Health (http://clinicaltrials.gov/ct2/home), World Health Organization International Clinical Trials Registry Platform search portal (www.who.int/trialsearch/Default.aspx) (inception to 17 April 2014). </p> </li> <li> <p><i>The Cochrane Library</i> (www.cochrane.org/index.htm) for the Database of Abstracts of Reviews of Effects (DARE) (inception to 17 April 2014). </p> </li> </ul> </p> <p>The MEDLINE search was combined with the Cochrane highly sensitive search strategy for identifying randomised trials which appears in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Version 5.0.2, chapter 6, 6.4.11). The EMBASE search was combined with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (see www.sign.ac.uk/mehodology/filters.html#random).    </p> <p>The detailed search strategies are presented in: <a href="./appendices#CD005073-sec-0107">Appendix 1</a>; <a href="./appendices#CD005073-sec-0108">Appendix 2</a>; <a href="./appendices#CD005073-sec-0109">Appendix 3</a>; <a href="./appendices#CD005073-sec-0110">Appendix 4</a>; <a href="./appendices#CD005073-sec-0111">Appendix 5</a>; <a href="./appendices#CD005073-sec-0112">Appendix 6</a> and <a href="./appendices#CD005073-sec-0113">Appendix 7</a>. </p> </section> <section id="CD005073-sec-0032"> <h4 class="title">Searching other resources</h4> <p>Literature was also identified by requesting reference lists from interventional radiologists known to perform the procedure (identified by membership in a professional society of interventional radiologists) and authors of papers identified via other searches. The citation lists of relevant publications, review articles and included studies were also searched. We contacted authors of published and unpublished trials for additional information when necessary. There was no language restriction. </p> </section> </section> <section id="CD005073-sec-0033"> <h3 class="title" id="CD005073-sec-0033">Data collection and analysis</h3> <section id="CD005073-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two authors (AS and JKG) independently reviewed all the studies retrieved by the search for compliance with the inclusion criteria. </p> </section> <section id="CD005073-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Two authors (AS and JKG) independently assessed study characteristics and methodological details of all included studies and extracted information using a pre‐designed data collection tool. Differences in opinion were resolved by consultation with a third review author (MAL). Where additional information on trial methodology or the original trial data were required, corresponding authors were contacted. </p> </section> <section id="CD005073-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (AS and JKG) independently assessed study characteristics and methodological details of included studies using data extraction forms to assess the risk of bias in the included studies. Differences in opinion were to be resolved by consultation with a third review author (MAL). </p> <p>The included studies were assessed for risk of bias using the Cochrane risk of bias assessment tool (<a href="./references#CD005073-bbs2-0017" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) to assess: sequence generation; allocation concealment; blinding of participants, providers and outcome assessors; completeness of outcome data; selective outcome reporting; and other potential sources of bias. Two authors (AS and JKG) independently assessed these six domains, with any disagreements resolved by consensus or by discussion with a third author. The conclusions were presented in the 'Risk of bias' table and incorporated into the interpretation of the review findings by means of sensitivity analysis. </p> </section> <section id="CD005073-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <section id="CD005073-sec-0038"> <h5 class="title"><i>Dichotomous data</i> </h5> <p>For dichotomous data, the results were presented as Mantel‐Haenszel odds ratios (OR) with 95% confidence intervals (CI).  </p> </section> <section id="CD005073-sec-0039"> <h5 class="title"><i>Continuous data</i> </h5> <p>For continuous data, the mean difference (MD) and 95% CI was used if outcomes were measured in the same way between trials. We planned to use the standardised mean difference (SMD) to combine trials that measured the same outcome but used different scales, but this was not required. </p> </section> </section> <section id="CD005073-sec-0040"> <h4 class="title">Unit of analysis issues</h4> <p> Data were analysed per woman randomised.</p> </section> <section id="CD005073-sec-0041"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, levels of attrition were noted.</p> <p>For all outcomes, analyses were carried out on an intention‐to‐treat basis as far as possible, that is we attempted to include all participants randomised to each group in the analyses. Otherwise, only the available data were analysed and the denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. For dichotomous outcomes all randomised women were included but for continuous outcomes such as satisfaction rates we only used data that were presented by the trial authors. </p> </section> <section id="CD005073-sec-0042"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta‐analysis to provide a meaningful summary. Following meta‐analysis, statistical heterogeneity between the results of different studies was examined graphically by inspecting the scatter in the data points on the graphs and the overlap in their CIs and, more formally, by checking the results of the Chi<sup>2</sup> tests. If we identified substantial heterogeneity we planned to explore it by pre‐specified subgroup analysis.  </p> </section> <section id="CD005073-sec-0043"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty in detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and being alert for duplication of data. If there were 10 or more studies in an analysis, we planned to use a funnel plot to explore the possibility of small study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies). </p> </section> <section id="CD005073-sec-0044"> <h4 class="title">Data synthesis</h4> <p>Where appropriate, we pooled data from the primary studies using the Mantel‐Haenszel fixed‐effect model in the RevMan 5 software. </p> </section> <section id="CD005073-sec-0045"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If heterogeneity was present, we examined clinical considerations which theoretically could lead to heterogeneity. </p> </section> <section id="CD005073-sec-0046"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were planned for the primary outcomes to determine whether the conclusions were robust to arbitrary decisions made regarding the eligibility and analysis of the included studies. These analyses included consideration of whether conclusions would have differed if: </p> <p> <ol id="CD005073-list-0004"> <li> <p>eligibility was restricted to published studies;</p> </li> <li> <p>eligibility was restricted to studies without high risk of bias;</p> </li> <li> <p>a random‐effects model had been adopted.</p> </li> </ol> </p> <section id="CD005073-sec-0047"> <h5 class="title">Overall quality of the body of evidence: summary of findings table</h5> <p>We prepared a summary of findings table using Guideline Development Tool software. This table evaluated the overall quality of the body of evidence for the main review outcomes using GRADE criteria (study limitations that is risk of bias, consistency of effect, imprecision, indirectness and publication bias). Judgements about evidence quality (high, moderate or low) were justified, documented and incorporated into the reporting of results for each outcome. The outcomes evaluated using GRADE criteria were: satisfaction with treatment up to 24 months and 5 years, live birth rate, intra‐procedural adverse events, minor post‐procedural adverse events, major post‐procedural adverse events within one year, and further interventions within two years). See <a href="./full#CD005073-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005073-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005073-sec-0048"></div> <section id="CD005073-sec-0049"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD005073-sec-0123" title="">Characteristics of included studies</a> and <a href="./references#CD005073-sec-0124" title="">Characteristics of excluded studies</a>. </p> <section id="CD005073-sec-0050"> <h4 class="title">Results of the search</h4> <p>The search strategy identified 62 potentially relevant citations. Twelve of the 62 citations met the inclusion criteria of the review and were retrieved in full. These 12 citations originated from seven randomised trials, namely <a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>. The most recent publications have been used as the primary reference for each study as they give the long‐term follow‐up results. </p> </section> <section id="CD005073-sec-0051"> <h4 class="title">Included studies</h4> <p>Seven studies were included in the review. See the table <a href="./references#CD005073-sec-0123" title="">Characteristics of included studies</a>. </p> <p>Study design: all seven studies were RCTs.</p> <p>Participants: all women (n = 793) in the included studies had symptomatic fibroids that justified surgical treatment. Four studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) excluded women who desired future pregnancies. The <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> study did not specify the fertility plans of its participants even though the majority of women underwent myomectomy in the surgical arm. The <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> study included premenopausal women with fibroids who had unfinished reproductive plans. The size of the fibroids was a limiting factor in two studies (larger than 10 cm in <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a> and 12 cm in <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). All studies except <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a> specifically excluded women with submucosal fibroids and pedunculated subserosal fibroids, as at that time both of these were thought to be a contraindication for UAE. </p> <p>Interventions: three studies compared UAE versus hysterectomy (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>). Two studies (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) compared UAE with hysterectomy or myomectomy. In this study the type of surgery (hysterectomy or myomectomy) was the choice of the participant, depending on whether she wished to retain her uterus for fertility or other reasons: 8/51 women opted for myomectomy in the <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a> study and 53/62 in the <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> study. Two studies compared UAE with myomectomy (<a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). In <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> six women in the UAE group had a hysterectomy, two had a myomectomy and one a repeat embolization; in the myomectomy group two were converted to hysterectomy and one had a hysterectomy seven months later. </p> <p>Outcomes: the primary outcomes were patient satisfaction and live birth. Six studies reported on patient satisfaction with treatment up to 24 months (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) and two studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) also reported this at five years. <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> was the only study designed to report on live birth. Another study (<a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) reported the reproductive outcome of the small number of women who opted for myomectomy (8/51), but this was not intended as an outcome measure and has not been included in the meta‐analysis. </p> <p>Secondary outcome measures were adverse events (intra‐procedural, minor and major post‐procedural complications); further interventions; unscheduled readmission rates; cost effectiveness; FSH levels post‐procedure, fibroid recurrence rate, pregnancy and health‐related quality of life. Six studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) reported on adverse events, unscheduled visits, resumption of normal activities and length of hospital stay. The safety outcomes in <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>, namely intra‐procedural, minor and major post‐procedural complications, need for blood transfusion and unscheduled visits, were analysed by treatment received and have been excluded from the analysis for this review. Six studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) reported on further interventions within two years. Two of these studies ( <a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) reported the same outcome within five years. Unscheduled readmission rates within four to six weeks were reported by two studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). </p> <p>Cost effectiveness was analysed by looking at the duration of the procedure, length of hospital stay and resumption of normal activities. Two studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) reported on the time taken to carry out the procedure. The length of hospital stay was reported by all of the seven studies (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>). Five of these also reported on the time taken to resume normal activities (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>). </p> <p>Ovarian failure was assessed by the FSH levels post‐procedure. <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> was the only study to report this within six months. <a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a> and <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a> assessed long‐term ovarian failure by reporting this at two year follow‐up. </p> <p><a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> was the only study designed to look at the impact of the two procedures on fertility (pregnancy and live birth rates). It was also the only study which reported on recurrence of fibroids within two years. The <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a> trial reported the reproductive outcome of the small number of women who opted for myomectomy (8/51) but this was not intended as an outcome measure. </p> <p><a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> and <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> reported on health‐related quality of life. </p> <p>The time of follow‐up was longest in <a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a> and <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>, with results published after five years. <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> reported outcomes at one year and <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a> at two years. The duration of follow‐up in <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a> was intended to be two years but the published results only reported six months of follow‐up. We contacted the principal author and were informed that they were unable to continue with the follow‐up for two years as initially intended (<a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>). The mean follow‐up in <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> was 24.9 months. <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> reported the health‐related quality of life scores at six month follow up but the rate of complications was reported up to a maximum of 42 months. </p> </section> <section id="CD005073-sec-0052"> <h4 class="title">Excluded studies</h4> <p>All case series, review articles, letters, editorials and case reports were excluded. Only one RCT was excluded. The <a href="./references#CD005073-bbs2-0008" title="HaldK , KløwNE , QvigstadE , IstreO . Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Obstetrics and Gynecology2007;109:20‐7. ">Hald 2007</a> trial of 66 women compared clinical outcomes at six months after treatment with bilateral laparoscopic occlusion of the uterine artery versus uterine leiomyoma embolization. As this trial compared two similar methods of uterine artery occlusion (that is either by embolic or direct occlusion of the uterine arteries) it was not deemed eligible for this review. </p> </section> </section> <section id="CD005073-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD005073-fig-0001">Figure 1</a>; <a href="#CD005073-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD005073-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD005073-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005073-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD005073-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD005073-sec-0054"> <h4 class="title">Allocation</h4> <section id="CD005073-sec-0055"> <h5 class="title">Sequence generation</h5> <p>Risk of selection bias related to random sequence generation was low in six of the included studies. All used a computer‐generated sequence. One study did not clearly report the method of sequence generation used and was rated at unclear risk (<a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>). </p> </section> <section id="CD005073-sec-0056"> <h5 class="title">Allocation concealment</h5> <p>Risk of selection bias related to allocation concealment was low in five of the studies. They used remote randomisation (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>), consecutively numbered opaque, sealed envelopes (<a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>) or computer randomisation at the point of study entry (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). Two studies did not clearly report the method of allocation concealment used and were rated at unclear risk (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>). </p> </section> </section> <section id="CD005073-sec-0057"> <h4 class="title">Blinding</h4> <p>No blinding was possible in any of the trials as one of the treatment arms included surgery, that is hysterectomy or myomectomy. Therefore, risk of bias was high in all trials for subjective outcomes (such as satisfaction rates) and unclear for other outcomes such as complications and re‐intervention. It was possible that participant blinding might affect the number of readmissions in the immediate post‐operative period as often women are asked to report back with trivial symptoms if they have undergone any relatively new procedure. </p> </section> <section id="CD005073-sec-0058"> <h4 class="title">Incomplete outcome data</h4> <p>Incomplete outcome data were adequately addressed with an intention‐to‐treat analysis in four trials (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) and their risk of attrition bias was low. In one study (<a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>) intention‐to‐treat analysis was only used to evaluate efficiency. This trial also allowed women to change their allocated intervention. That is, three women assigned to the hysterectomy group underwent UAE and, therefore, the effectiveness and safety parameters were calculated on the actual treatment received (treatment received analysis). The risk of attrition bias was high in this study. Hence, for the review, data from the Pinto trial (<a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>) presented by intention‐to‐treat analysis only have been used. Also the length of follow‐up was meant to be 24 months but the published results were for six months only. We contacted the authors of this trial for the long‐term data and they sent us their 12 month unpublished data, which we could not use for this review because the mean data were incomplete. </p> <p>The risk of attrition bias in <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> was high as 23% of women randomised to UAE and 27% of those randomised to myomectomy were excluded from the analysis. The risk of attrition bias in <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> was low as only two women were lost to follow‐up. Also, in <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> the existing reproductive results could have been partially influenced by the short duration of the follow‐up. </p> </section> <section id="CD005073-sec-0059"> <h4 class="title">Selective reporting</h4> <p>There was no indication of selective reporting in any of the included studies and their risk of bias was low. All expected outcomes were reported in all studies. </p> </section> <section id="CD005073-sec-0060"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were identified in any of the included studies. The findings on quality of life in <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> differed according to whether change scores or end scores were used, apparently due to non‐statistically significant baseline differences between the groups; results for both measures were reported in the review. </p> </section> </section> <section id="CD005073-sec-0061"> <h3 class="title" id="CD005073-sec-0061">Effects of interventions</h3> <p>See: <a href="./full#CD005073-tbl-0001"><b>Summary of findings for the main comparison</b> Uterine artery embolization (UAE) compared to surgery for symptomatic uterine fibroids</a> </p> <section id="CD005073-sec-0062"> <h4 class="title">Primary outcomes</h4> <section id="CD005073-sec-0063"> <h5 class="title">1. Patient satisfaction</h5> <section id="CD005073-sec-0064"> <h6 class="title">UAE versus any type of surgery</h6> <p>All but one study reported this outcome. Satisfaction rates were measured by asking women whether they would undergo the same treatment again (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) or whether they obtained symptom relief (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> did not specify the criteria for measuring the satisfaction rate. </p> <p>The evidence was inconclusive as CIs were consistent with satisfaction rates, being up to 41% lower or up to 48% higher with UAE compared to surgery within 12 to 24 months of having the procedure (OR 0.94; 95% CI 0.59 to 1.48, 6 trials, 640 women, I<sup>2</sup> = 5%, moderate quality evidence) (<a href="./references#CD005073-fig-0007" title="">Analysis 1.1</a>, <a href="#CD005073-fig-0003">Figure 3</a>). Findings were also inconclusive at five years of follow‐up (OR 0.90; 95% CI 0.45 to 1.80, 2 trials, 295 women, I<sup>2</sup> = 0%, moderate grade evidence) (<a href="./references#CD005073-fig-0008" title="">Analysis 1.2</a>, <a href="#CD005073-fig-0004">Figure 4</a>). No meaningful heterogeneity was detected. </p> <div class="figure" id="CD005073-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.1 Satisfaction with treatment up to 24 months." data-id="CD005073-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.1 Satisfaction with treatment up to 24 months. </p> </div> </div> </div> <div class="figure" id="CD005073-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.2 Satisfaction with treatment at 5 years." data-id="CD005073-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.2 Satisfaction with treatment at 5 years. </p> </div> </div> </div> </section> <section id="CD005073-sec-0065"> <h6 class="title">UAE versus specific types of surgery</h6> <p>Analyses were stratified by type of surgery.</p> <p>At 12 to 24 months the findings were similarly inconclusive in comparisons of UAE versus hysterectomy (OR 0.63; 95% CI 0.30 to 1.32, 3 trials, 266 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>), versus either hysterectomy or myomectomy (OR 1.04; 95% CI 0.94 to 1.15, 2 trials, 264 women) (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) and versus myomectomy (OR 1.05; 95% CI 0.33 to 3.36, 1 trial, 110 women) (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). At five years the findings remained inconclusive in comparisons of UAE versus hysterectomy (OR 0.71; 95% CI 0.29 to 1.78, 1 trial, 156 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>) and versus either hysterectomy or myomectomy (OR 1.25; 95% CI 0.42 to 3.67, 1 trial, 139 women) (<a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>). </p> </section> </section> <section id="CD005073-sec-0066"> <h5 class="title">2. Live birth</h5> <section id="CD005073-sec-0067"> <h6 class="title">UAE versus myomectomy</h6> <p>Live birth was calculated from the limited cohort of participants who tried to conceive in one study of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>): 26 women after UAE and 40 after myomectomy. The evidence suggested that UAE may be associated with a lower live birth rate than surgery (OR 0.26; 95% CI 0.08 to 0.84, 1 trial, 66 women, very low quality evidence) (<a href="./references#CD005073-fig-0009" title="">Analysis 1.3</a>, <a href="#CD005073-fig-0005">Figure 5</a>), but CIs were also assiciated with no meaningful difference between the interventions. This finding should be regarded with extreme caution as it was based on a subgroup analysis of those stating a desire to conceive. </p> <div class="figure" id="CD005073-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.3 Live birth." data-id="CD005073-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.3 Live birth.</p> </div> </div> </div> <p>Although <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a> was not specifically designed to compare UAE versus myomectomy, this study reported fertility outcomes in a comparison between the UAE arm and a subgroup of eight women in the surgical arm (8/51) who opted for myomectomy rather than hysterectomy. There were four births in the UAE group (4/106) and two in the myomectomy group (2/8). These data were not included in analysis due to the strong risk of selection bias. </p> </section> </section> </section> <section id="CD005073-sec-0068"> <h4 class="title">Secondary outcomes</h4> <section id="CD005073-sec-0069"> <h5 class="title">1. Adverse events</h5> <section id="CD005073-sec-0070"> <h6 class="title">UAE versus any type of surgery</h6> <p>All seven studies reported complications, at varying time points. The data from <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a> were not included in the analysis as the study did not utilise the intention‐to‐treat principle to report safety and complications. </p> <p>When studies were pooled, the findings were inconclusive. CIs suggested substantially higher rates of complications in either arm, or no difference between the groups in the rate of intra‐procedural complications (OR 0.91; 95% CI 0.42 to 1.97, 4 trials, 452 women, I<sup>2</sup> = 40%, low quality evidence) (<a href="./references#CD005073-fig-0010" title="">Analysis 1.4</a>), major complications within one year (OR 0.65; 95% CI 0.33 to 1.26, 5 trials, 611 women, I<sup>2</sup> = 4%, moderate quality evidence) (<a href="./references#CD005073-fig-0013" title="">Analysis 1.7</a>) or major complications within five years (OR 0.56; CI 0.27 to 1.18, 2 trials, 268 women) (<a href="./references#CD005073-fig-0015" title="">Analysis 1.9</a>). </p> <p>However, the rate of minor complications within one year was higher in the UAE group (OR 1.99; CI 1.41 to 2.81, 6 trials, 735 women, I<sup>2</sup> = 0%, moderate quality evidence) (<a href="./references#CD005073-fig-0012" title="">Analysis 1.6</a>). Longer‐term minor complications were reported in three trials at differing periods of follow‐up. One found no difference between the groups in minor complications at one month to two years (OR 1.82; 95% CI 0.56 to 5.94, 1 trial, 120 women) (<a href="./references#CD005073-fig-0014" title="">Analysis 1.8</a>). The other two trials (of UAE versus hysterectomy or myomectomy) found a higher minor complication rate in the UAE group up to five years (OR 2.93; CI 1.73 to 4.93, 2 trials, 268 women) (<a href="./references#CD005073-fig-0014" title="">Analysis 1.8</a>). </p> <p>The evidence suggested that women in the UAE group were less likely to require a blood transfusion than women receiving surgery (OR 0.07; 95% CI 0.01 to 0.52, 2 trials, 277 women, I<sup>2</sup> = 0%) (<a href="./references#CD005073-fig-0011" title="">Analysis 1.5</a>). </p> </section> <section id="CD005073-sec-0071"> <h6 class="title">UAE versus specific types of surgery</h6> <p>Analyses were stratified by type of surgery.</p> <p>In comparisons of UAE versus hysterectomy, there was no evidence of a difference between the groups in the rate of intra‐procedural complications, blood transfusions or major complications within one year. However, there were more minor complications in the UAE group than in the hysterectomy group within one year (OR 2.12; 95% CI 1.13 to 3.96, 2 trials, 211 women, I<sup>2</sup> = 0%) (<a href="./references#CD005073-fig-0012" title="">Analysis 1.6</a>). In the comparison of UAE versus hysterectomy or myomectomy (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) there were more minor complications within five years (OR 2.93; CI 1.73 to 4.93, 268 women) (<a href="./references#CD005073-fig-0014" title="">Analysis 1.8</a>). There was no evidence of a difference regarding major complications at one or five years (<a href="./references#CD005073-fig-0013" title="">Analysis 1.7</a>, <a href="./references#CD005073-fig-0015" title="">Analysis 1.9</a>). In comparisons of UAE versus myomectomy, there was no conclusive evidence of a difference between UAE and myomectomy in the rate of intra‐procedural complications (<a href="./references#CD005073-fig-0010" title="">Analysis 1.4</a>), the rate of any complications within the first month (<a href="./references#CD005073-fig-0012" title="">Analysis 1.6</a>) or for up to two years (<a href="./references#CD005073-fig-0014" title="">Analysis 1.8</a>). </p> <p>A wide CI also made it difficult to draw conclusive evidence with regard to the need for blood transfusion in comparisons of UAE and myomectomy (OR 0.21; 95% CI 0.01 to 4.47, 121 women) (<a href="./references#CD005073-fig-0011" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD005073-sec-0072"> <h5 class="title">2. Further interventions</h5> <section id="CD005073-sec-0073"> <h6 class="title">UAE versus any type of surgery</h6> <p>Five studies reported the rate of further interventions within two years, and two studies reported the rate after five years of follow‐up (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>). When the studies were pooled there was a higher likelihood of requiring further surgical intervention in women undergoing UAE, both within two years (OR 3.72; 95% CI 2.28 to 6.04, 6 trials, 732 women, I<sup>2</sup> = 45%, moderate quality evidence) (<a href="./references#CD005073-fig-0016" title="">Analysis 1.10</a>, <a href="#CD005073-fig-0006">Figure 6</a>) and at five years (OR 5.79; 95% CI 2.65 to 12.65, 2 trials, 289 women, I<sup>2</sup> = 65%) (<a href="./references#CD005073-fig-0017" title="">Analysis 1.11</a>). </p> <div class="figure" id="CD005073-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.10 Further interventions within 2 years." data-id="CD005073-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.10 Further interventions within 2 years. </p> </div> </div> </div> </section> <section id="CD005073-sec-0074"> <h6 class="title">UAE versus specific types of surgery</h6> <p>Analyses were stratified by type of surgery. In comparisons of UAE versus hysterectomy, further interventions were more likely in the UAE group than in the surgical group within two years (OR 2.99; 95% CI 1.31 to 6.80, 2 trials, 209 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>) and at five years (OR 3.43; 95% CI 1.41 to 8.30, 1 trial, 145 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>). In the comparison of UAE versus hysterectomy or myomectomy (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>), further interventions were also more likely in the UAE group than in the surgical group within two years (OR 2.83; 95% CI 1.29 to 6.24, 281 women) and at five years (OR 20.34; 95% CI 2.68 to 154.59, 144 women). Similarly, in the comparison of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) further interventions were more likely in the UAE group than in the surgical group within two years (OR 6.89; 95% CI 2.60 to 18.27, 242 women). </p> </section> </section> <section id="CD005073-sec-0075"> <h5 class="title">3. Unscheduled visits and readmissions</h5> <section id="CD005073-sec-0076"> <h6 class="title">UAE versus any type of surgery</h6> <p>Three studies reported this outcome. Data from <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a> were excluded. There was a higher rate of unscheduled visits or readmissions within 4 to 6 weeks in the UAE group (OR 2.74; 95% CI 1.42 to 5.26, 2 trials, 278 women, I<sup>2</sup> = 0%) (<a href="./references#CD005073-fig-0018" title="">Analysis 1.12</a>). </p> </section> <section id="CD005073-sec-0077"> <h6 class="title">UAE versus specific types of surgery</h6> <p>Analyses were stratified by type of surgery. In comparisons of UAE versus hysterectomy, unscheduled visits or readmissions within six weeks were more likely in the UAE group than in the surgical group (OR 2.79; 95% CI 1.41 to 5.49, 1 trial, 157 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>). In the comparison of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) CIs were extremely wide and suggested higher or lower rates of unscheduled visits or readmissions within four weeks in either group, or no difference between the groups (OR 2.21; 95% CI 0.20 to 25.09, 121 women). </p> </section> </section> <section id="CD005073-sec-0078"> <h5 class="title">4. Cost</h5> <p>The duration of the procedure, length of hospital stay and resumption of normal activities were used as surrogate markers for cost. </p> <section id="CD005073-sec-0079"> <h6 class="title">Duration of procedure</h6> <section id="CD005073-sec-0080"> <p><b>UAE versus any type of surgery</b></p> <p>Two studies reported this outcome. They were not pooled due to highly significant statistical heterogeneity (P &lt; 0.00001) attributable to the differing types of surgery used. </p> </section> <section id="CD005073-sec-0081"> <p><b>UAE versus specific types of surgery</b></p> <p>Analyses were stratified by type of surgery (<a href="./references#CD005073-fig-0019" title="">Analysis 1.13</a>). In a comparison of UAE versus hysterectomy (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>), the duration of the procedure was shorter in the UAE group (MD ‐16.40 min, 95% CI ‐26.04 to ‐6.76, 1 trial, 156 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>). In the comparison of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) the duration of the procedure was also shorter in the UAE group but with a more marked difference (MD ‐49.70 min, 95% CI ‐58.76 to ‐40.64, 121 women). </p> </section> </section> <section id="CD005073-sec-0082"> <h6 class="title">Length of hospital stay</h6> <section id="CD005073-sec-0083"> <p><b>UAE versus any type of surgery</b></p> <p>All studies reported this outcome. They were not pooled due to highly significant statistical heterogeneity (P &lt; 0.00001) attributable to the differing types of surgery used. </p> </section> <section id="CD005073-sec-0084"> <p><b>UAE versus specific types of surgery</b></p> <p>Analyses were stratified by type of surgery (<a href="./references#CD005073-fig-0020" title="">Analysis 1.14</a>). In the comparison of UAE versus hysterectomy, length of hospital stay was shorter in the UAE group in all three studies, with the MD ranging from 2.2 days (95% CI 1.6 to 2.8) in <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a> to 4.14 days (95% CI 2.9 to 5.38) in <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>. These studies were not pooled due to high heterogeneity (I<sup>2</sup> = 79%). In the comparison of UAE versus hysterectomy or myomectomy (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) the length of hospital stay was also shorter in the UAE group: <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a> found a MD of 3.10 days (95% CI 2.55 to 3.65) and <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> found a MD of 3.4 days (95% CI 2.03 to 4.77). In the comparison of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>; <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>), length of hospital stay was also shorter in the UAE group: <a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> found a MD of 1.10 days (95% CI 0.56 to 1.64) and <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> found a MD of 4 days (95% CI 3.03 to 4.97). These studies were not pooled due to high heterogeneity (I<sup>2</sup> = 96%). </p> </section> </section> <section id="CD005073-sec-0085"> <h6 class="title">Time to resumption of normal activities</h6> <section id="CD005073-sec-0086"> <p><b>UAE versus any type of surgery</b></p> <p>Six studies reported this outcome (<a href="./references#CD005073-fig-0021" title="">Analysis 1.15</a>) but the data from <a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a> have been excluded from the analysis. The comparison of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) was not included in the pooled analysis as this resulted in highly significant statistical heterogeneity (P &lt; 0.00001), explicable by the different type of surgery in this comparison. When the other four studies were analysed, the time to resumption of normal activities was shorter in the UAE group compared to any other surgical intervention (<a href="./references#CD005073-fig-0021" title="">Analysis 1.15</a>). </p> </section> <section id="CD005073-sec-0087"> <p><b>UAE versus specific types of surgery</b></p> <p>Analyses were stratified by type of surgery (<a href="./references#CD005073-fig-0021" title="">Analysis 1.15</a>). In the comparison of UAE versus hysterectomy, time to resumption of normal activities was shorter in the UAE group (MD ‐22.85 days; 95% CI ‐27.30 to ‐18.40, 2 trials, 188 women) (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0007" title="RuuskanenA , HippelainenM , SipolaP , ManninenH . Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2‐year follow‐up results of a randomised prospective clinical trial. European Radiology2010;20(10):2524‐32. ">Ruuskanen 2010</a>). Similarly, in the comparison of UAE versus hysterectomy or myomectomy (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) the time to resumption of normal activities was shorter in the UAE group (MD ‐13.68 days; 95% CI ‐16.05 to ‐11.30, 220 women). In a comparison of UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>), time to resumption of normal activities was also shorter in the UAE group but the difference was less marked (MD ‐10.20 days; 95% CI ‐13.60, to ‐6.80, 121 women). </p> </section> </section> </section> <section id="CD005073-sec-0088"> <h5 class="title">5. FSH levels as an indicator of ovarian failure</h5> <section id="CD005073-sec-0089"> <h6 class="title">UAE versus any type of surgery</h6> <p>Three studies reported this outcome, using differing thresholds for the FSH level. In two studies, which reported the number of women with FSH levels over 40 IU/L within two years (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>), there was no evidence of a difference between the groups (OR 1.01; 95% CI 0.53 to 1.94, 297 women) (<a href="./references#CD005073-fig-0022" title="">Analysis 1.16</a>). One study reporting the number of women with FSH over 10 IU/L within six months (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) also found no conclusive evidence of a difference between the groups (OR 4.80; 95% CI 0.97 to 23.64, 120 women) (<a href="./references#CD005073-fig-0023" title="">Analysis 1.17</a>). </p> </section> <section id="CD005073-sec-0090"> <h6 class="title">UAE versus specific types of surgery</h6> <p>Analyses were stratified by type of surgery. There was no significant difference between the groups for this outcome in individual comparisons of UAE versus hysterectomy (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>), UAE versus hysterectomy or myomectomy (<a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) or UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>). </p> </section> </section> <section id="CD005073-sec-0091"> <h5 class="title">6. Fibroid recurrence rate</h5> <p>One of the studies comparing UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) looked at the recurrence rate of fibroids within two years of follow‐up. There was inconclusive evidence of a difference between the groups as the CI was very wide (OR 1.32; 95% CI 0.38 to 4.57, 120 women) (<a href="./references#CD005073-fig-0024" title="">Analysis 1.18</a>). </p> </section> <section id="CD005073-sec-0092"> <h5 class="title">7. Pregnancy rate</h5> <p>One of the studies comparing UAE versus myomectomy (<a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a>) reported this outcome. The pregnancy rate was calculated from the limited cohort of participants who tried to conceive (26 women after UAE and 40 after myomectomy). There were fewer pregnancies in the UAE group (OR 0.29; 95% CI 0.10 to 0.85, 66 women) (<a href="./references#CD005073-fig-0025" title="">Analysis 1.19</a>) but the CIs showed no evidence of a difference between the interventions. This finding should be regarded with extreme caution as it was based on a subgroup analysis of those stating a desire to conceive. </p> <p>Although <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a> was not specifically designed to compare UAE versus myomectomy, this study reported fertility outcomes in a comparison between the UAE arm and a subgroup of eight women in the surgical arm (8/51) who opted for myomectomy rather than hysterectomy. There were 10 pregnancies in the UAE group (10/106) and two in the myomectomy group (2/8). These data were not included in the analysis due to the strong risk of selection bias. </p> </section> <section id="CD005073-sec-0093"> <h5 class="title">8. Health‐related quality of life</h5> <p>Three trials reported health‐related quality of life. The <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a> study used the UFS‐QOL self‐administered questionnaire whilst the Medical Outcomes Study 36‐Item Short Form General Health Survey (SF‐36) was used in <a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a> and <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011.</a> Both these measures use a 0 to 100 scale. </p> <p>In <a href="./references#CD005073-bbs2-0002" title="ManyondaIT , BratbyM , HorstJS , BanuN , GortiM , BelliA‐M . Uterine artery embolization versus myomectomy: Impact on quality of life ‐ results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology2012;35(3):530‐6. ">FUME 2012</a>, when the overall UFS‐QOL scores at one year follow‐up were compared, they were significantly higher in the myomectomy group than in the UAE group (MD ‐13.40; 95% CI ‐ 21.41 to ‐5.39, 122 women). However, the study authors noted that scores were (non‐significantly) lower at baseline in the UAE group. When mean changes in score from baseline were compared there was little clinically meaningful difference between the two groups (MD ‐7.60; 95% CI ‐17.55 to ‐2.35, 122 women). There was an improvement from baseline in overall quality of life in both groups. </p> <p>Two trials (<a href="./references#CD005073-bbs2-0003" title="JunF , YaminL , XinliX , ZheL , MinZ , BoZ , WenliG . Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta‐analysis of the literature. Archives of Gynecology and Obstetrics2012;285:1407‐13. ">Jun 2012</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>) reported SF‐36 quality of life (QoL) outcome measures at 6 and 12 months, respectively, on an 11 point score. Surgery was associated with a greater improvement in QoL at 1 year than UAE (MD 9.14; 95% CI 8.04 to 10.23, 281 women). This was of borderline clinical significance (the difference in QoL score seemed to be similar in both cases (7% versus 9%)). </p> </section> </section> <section id="CD005073-sec-0094"> <h4 class="title">Sensitivity analyses</h4> <p>Use of a random‐effects model did not materially change any of the effect estimates. There were insufficient studies to conduct other planned sensitivity analyses. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005073-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005073-sec-0095"></div> <section id="CD005073-sec-0096"> <h3 class="title" id="CD005073-sec-0096">Summary of main results</h3> <p>This Cochrane review summarises the current evidence on the effectiveness of UAE compared to surgery (hysterectomy or myomectomy) as a treatment option for symptomatic uterine fibroids. The evidence on satisfaction rates was inconclusive in spite of a higher rate of post‐procedural complications and further re‐interventions in the UAE arm of the studies. Our findings showed evidence of benefit or harm from either intervention, or of no difference between the interventions. </p> <p><a href="./references#CD005073-bbs2-0004" title="MaraM , FucikovaaZ , MaskovaJ , KuzelaJ , HaakovaL . Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2006;126:226‐33. MaraM , MaskovaJ , FucikovaZ , KuzelD , BelsanT , SosnaO . Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology2008;31:73‐85. ">Mara 2008</a> was the only study which specifically looked at the impact of UAE versus myomectomy on fertility, an important parameter as both are uterine‐sparing procedures. The findings for live birth suggested a possible benefit from myomectomy. However, as noted above, this finding should be regarded with extreme caution as it was based on a subgroup analysis of those stating a desire to conceive, and the confidence intervals were evidence of no meaningful difference between the interventions. </p> <p>UAE was advantageous over hysterectomy or myomectomy with regard to a shorter hospital stay, a quicker return to full activity, and reduced likelihood of a need for blood transfusion. However, UAE was associated with an increased short‐term (within one year) and up to five year risk of minor complications. Findings with regard to major complications were inconclusive. </p> <p>In the previous version of this review, the authors concluded that the women opting for UAE should be counselled about a higher surgical intervention rate in the longer term. This is supported by the five year follow‐up data from the EMMY and REST trials. There is a five‐fold increase in the likelihood of needing further intervention after UAE. Although UAE initially appears to be a cost effective alternative to hysterectomy, the long‐term follow‐up at five years shows that this advantage is lost due to a subsequent higher rate of re‐intervention (<a href="./references#CD005073-bbs2-0001" title="HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology2006;29:179‐87. HehenkampWJK , VolkersNA , BirnieE , ReekersJA , AnkumWM . Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy ‐ results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology2008;246(3):823‐32. HehenkampWJK , VolkersNA , BroekmansFJM , deJongFH , ThemmenAPN , BirnieE , et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction2007;22:1996‐2005. HehenkampWJK , VolkersNA , DonderwinkelPFJ , deBlokS , BirnieE , AnkumWA , et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri‐ and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology2005;193:1618‐29. VolkersNA , HehenkampWJ , SmitP , AnkumWM , ReekersJA , BirnieE . Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology2008;19:1007‐17. VolkersNA , HehenkampWJK , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2007;196:519e.1‐11. van derKooijSM , HehenkampWJK , VolkersNA , BirnieE , AnkumWM , ReekersJA . Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5‐year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology2010;203:105.e1‐13. ">EMMY 2010</a>; <a href="./references#CD005073-bbs2-0006" title="EdwardsRD , MossJG , LumsdenMA , WuO , MurrayLS , TwaddleS , et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine2007;356:360‐70. MossJG , CooperKG , KhaundA , MurrayLS , MurrayGD , WuO , et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology2011;118(8):936‐44. RashidS , KhaundA , MurrayLS , MossJG , CooperK , LyonsD , et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology2010;117:985‐9. ">REST 2011</a>). Surgery was also associated with a slight improvement in quality of life compared to UAE but this might not be clinically meaningful. </p> <p>See also 'Summary of findings' table 3.</p> </section> <section id="CD005073-sec-0097"> <h3 class="title" id="CD005073-sec-0097">Overall completeness and applicability of evidence</h3> <p>This Cochrane review was performed according to the current standards of The Cochrane Collaboration and the Menstrual Disorders and Subfertility Group. Applicability and completeness of this review reflect the study characteristics and completeness by which they were reported. Even though the primary outcome measures differed for different trials, they collected similar outcome data, which made this review possible. Given that UAE is a uterine‐sparing procedure, there was only one trial comparing it with another uterine‐sparing procedure (myomectomy) that reported on fertility and pregnancy outcomes. </p> <p>Current findings apply to women similar to the populations of the included studies: premenopausal women with menorrhagia caused by uterine fibroids, confirmed either by ultrasonography or MRI, and fit to undergo surgical treatment. Review findings apply to the time frame of six months to five years after the intervention. </p> </section> <section id="CD005073-sec-0098"> <h3 class="title" id="CD005073-sec-0098">Quality of the evidence</h3> <p>The quality of the evidence had a wide range and was very low for live birth, moderate for satisfaction ratings, and moderate for most safety outcomes. The main limitations in the evidence were serious imprecision due to wide confidence intervals, failure to clearly report methods, and lack of blinding for subjective outcomes. There was only one trial subgroup which examined fertility outcomes, and this limits the possibility of drawing any conclusions regarding the effects of UAE on fertility and pregnancy. Overall, the imprecision of the findings meant that few firm conclusions could be drawn. </p> <p>A detection bias may be present for subjective outcomes as blinding was not performed. Participant blinding may not be feasible due to ethical issues, and blinding of the physician is not practical. It is possible that participant blinding might have affected the number of readmissions in the immediate post‐operative period as often women are asked to report back with trivial symptoms if they have undergone any relatively new procedure. The most important consideration was study power. The RCTs were all limited by relatively small samples. Power issues underline the importance of meta‐analysis. </p> </section> <section id="CD005073-sec-0099"> <h3 class="title" id="CD005073-sec-0099">Potential biases in the review process</h3> <p>The strength of this review lies in the application of Cochrane methodology. An extensive literature search was applied, therefore we believe that the likelihood is quite high that all relevant studies were identified. </p> </section> <section id="CD005073-sec-0100"> <h3 class="title" id="CD005073-sec-0100">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are in keeping with the results of the systematic review commissioned by NICE (<a href="./references#CD005073-bbs2-0012" title="ColemanP . Review body for interventional procedures, Sheffield: Commissioned by the National Institute for Clinical Excellence. National Institute for Clinical Excellence2004. ">Coleman 2004</a>). This review was based on one RCT (<a href="./references#CD005073-bbs2-0005" title="PintoI , ChimenoP , RomoL , HayaJ , De laCalM , BajoJ . Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology2003;226(2):425‐31. ">Pinto 2003</a>), two comparative studies, one patient questionnaire survey, and 32 papers from 25 case series. The review concluded that there was a reduction in mean uterine volume of 26% to 59% and fibroid volume of 40% to 75% in the first six months following UAE. In studies with longer follow‐up, this was shown to continue in most women. The review quoted the clinical success rate, that is improvement of symptoms, mainly menorrhagia, to be in the range of 60% to 90%. </p> <p>The findings are further supported by another large cohort study (<a href="./references#CD005073-bbs2-0018" title="DuttonS , HirstA , McPhersonK , NicholsonT , MareshM . A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium‐term safety and efficacy. British Journal of Obstetrics and Gynaecology2007;114:1340‐51. ">HOPEFUL 2007</a>). This was a multi‐centre retrospective study comparing the experiences of two representative cohorts of women who received one of two alternative treatments for symptomatic fibroids from the mid‐1990s (hysterectomy, N = 459; UAE, N = 649). More women in the hysterectomy cohort reported relief from fibroid symptoms (95% versus 85%, P &lt; 0.0001) but only 85% would recommend the treatment to a friend compared with 91% in the UAE arm. There was a 23% (95% CI 19% to 27%) chance of requiring further treatment for fibroids after UAE at a mean follow‐up of 4.6 years, which is similar to the findings of the current review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005073-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD005073-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD005073-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.1 Satisfaction with treatment up to 24 months." data-id="CD005073-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.1 Satisfaction with treatment up to 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.2 Satisfaction with treatment at 5 years." data-id="CD005073-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.2 Satisfaction with treatment at 5 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.3 Live birth." data-id="CD005073-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.3 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 UAE versus surgery, outcome: 1.10 Further interventions within 2 years." data-id="CD005073-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 UAE versus surgery, outcome: 1.10 Further interventions within 2 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 1 Satisfaction with treatment up to 24 months." data-id="CD005073-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 1 Satisfaction with treatment up to 24 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 2 Satisfaction with treatment at 5 years." data-id="CD005073-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 2 Satisfaction with treatment at 5 years.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 3 Live birth." data-id="CD005073-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 3 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 4 Adverse events: intraprocedural complications." data-id="CD005073-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 4 Adverse events: intraprocedural complications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 5 Adverse events: Need for blood transfusion." data-id="CD005073-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 5 Adverse events: Need for blood transfusion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 6 Adverse events: minor postprocedural complications." data-id="CD005073-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 6 Adverse events: minor postprocedural complications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 7 Adverse events: major postprocedural complications within one year." data-id="CD005073-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 7 Adverse events: major postprocedural complications within one year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 8 Adverse events: later minor postprocedural complications." data-id="CD005073-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 8 Adverse events: later minor postprocedural complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 9 Adverse events: major postprocedural complications." data-id="CD005073-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 9 Adverse events: major postprocedural complications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-10.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 10 Further interventions within 2 years." data-id="CD005073-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 10 Further interventions within 2 years.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 11 Further interventions within 5 years." data-id="CD005073-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 11 Further interventions within 5 years.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 12 Unscheduled readmission rate within 4‐6 weeks." data-id="CD005073-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 12 Unscheduled readmission rate within 4‐6 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 13 Cost: duration of procedure (minutes)." data-id="CD005073-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 13 Cost: duration of procedure (minutes).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 14 Cost: length of hospital stay (days)." data-id="CD005073-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 14 Cost: length of hospital stay (days).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 15 Cost: resumption of normal activities (days)." data-id="CD005073-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 15 Cost: resumption of normal activities (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 16 FSH levels &gt;40 IU/L (within 2 years)." data-id="CD005073-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 16 FSH levels &gt;40 IU/L (within 2 years).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 17 FSH levels &gt;10 IU/L (within 6 months)." data-id="CD005073-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 17 FSH levels &gt;10 IU/L (within 6 months).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 18 Fibroid recurrence within 2 years." data-id="CD005073-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 18 Fibroid recurrence within 2 years.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 19 Pregnancy." data-id="CD005073-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 19 Pregnancy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 20 UAE versus myomectomy: Health related quality of life at one year." data-id="CD005073-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 20 UAE versus myomectomy: Health related quality of life at one year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005073-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/urn:x-wiley:14651858:media:CD005073:CD005073-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_t/tCD005073-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 UAE versus surgery, Outcome 21 UAE versus hysterectomy or myomectomy: SF‐36 within 1 year." data-id="CD005073-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 UAE versus surgery, Outcome 21 UAE versus hysterectomy or myomectomy: SF‐36 within 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/media/CDSR/CD005073/image_n/nCD005073-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005073-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Uterine artery embolization (UAE) compared to surgery for symptomatic uterine fibroids</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>UAE compared to surgery for symptomatic uterine fibroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women with symptomatic uterine fibroids<br/> <b>Intervention:</b> UAE<br/> <b>Comparison:</b> surgery </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Surgery</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> UAE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with treatment up to 24 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>861 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>853 per 1000<br/> (785 to 901) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.94<br/> (0.59 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>640<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with treatment at 5 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>876 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>864 per 1000<br/> (761 to 927) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.90<br/> (0.45 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>295<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth ‐ UAE versus myomectomy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>475 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1000<br/> (67 to 432) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.26<br/> (0.08 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: intra‐procedural complications</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000<br/> (27 to 117) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.91<br/> (0.42 to 1.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>452<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>5,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: minor post‐procedural complications within one year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>230 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>373 per 1000<br/> (296 to 456) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.99<br/> (1.41 to 2.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>735<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: major post‐procedural complications within one year</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000<br/> (24 to 85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.65<br/> (0.33 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>611<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,5,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Further interventions within 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1000<br/> (149 to 317) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 3.72<br/> (2.28 to 6.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>732<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1,2,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Studies unblinded </p> <p><sup>2</sup>Two studies did not fully explain randomisation and allocation concealment, but quality not downgraded for this as their omission from analysis did not substantially change the findings </p> <p><sup>3</sup> Wide confidence intervals compatible with substantial harm from UAE or with no effect </p> <p><sup>4</sup>Includes only those trial participants who wished to conceive (66/121) </p> <p><sup>5</sup>One study did not fully explain methods of randomisation and allocation concealment, but omission of this study did not substantially affect the findings </p> <p><sup>6</sup>Low event rate </p> <p><sup>7</sup>Wide confidence intervals compatible with substantial harm or benefit from either intervention, or with no effect </p> <p><sup>8</sup>Some statistical heterogeneity (I<sup>2</sup> = 45%); quality not downgraded for this as direction of effect is consistent </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Uterine artery embolization (UAE) compared to surgery for symptomatic uterine fibroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/full#CD005073-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005073-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">UAE versus surgery</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Satisfaction with treatment up to 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.59, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.30, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.64, 2.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.33, 3.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Satisfaction with treatment at 5 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.45, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.29, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.42, 3.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.08, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events: intraprocedural complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.42, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.44, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.18, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events: Need for blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.01, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.00, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events: minor postprocedural complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>735</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.99 [1.41, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.12 [1.13, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.51 [1.49, 4.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.62, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse events: major postprocedural complications within one year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.33, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.22, 4.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.30, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.06, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse events: later minor postprocedural complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 UAE versus hysterectomy or myomectomy (to 5 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [1.73, 4.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 UAE versus myomectomy (1 month‐2 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.56, 5.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Adverse events: major postprocedural complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.27, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 UAE versus hysterectomy or myomectomy (to 5 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.27, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 UAE versus myomectomy (1 month‐2 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Further interventions within 2 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>732</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.72 [2.28, 6.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.99 [1.31, 6.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.83 [1.29, 6.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.89 [2.60, 18.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Further interventions within 5 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.79 [2.65, 12.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.43 [1.41, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.34 [2.68, 154.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Unscheduled readmission rate within 4‐6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.05, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.09, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Cost: duration of procedure (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.40 [‐26.04, ‐6.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐49.7 [‐58.76, ‐40.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Cost: length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Cost: resumption of normal activities (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐22.85 [‐27.30, ‐18.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.68 [‐16.05, ‐11.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.20 [‐13.60, ‐6.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 FSH levels &gt;40 IU/L (within 2 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.53, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 UAE versus hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.32, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 UAE versus hysterectomy or myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.35 [0.64, 8.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 FSH levels &gt;10 IU/L (within 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.8 [0.97, 23.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.8 [0.97, 23.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Fibroid recurrence within 2 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.38, 4.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.38, 4.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.10, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 UAE versus myomectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.10, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 UAE versus myomectomy: Health related quality of life at one year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 USF‐QOL end scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.40 [‐21.41, ‐5.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 USF‐QOL change scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.60 [‐17.55, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 UAE versus hysterectomy or myomectomy: SF‐36 within 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.14 [8.04, 10.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Physical function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.77 [5.83, 9.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 Social function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.14 [2.71, 9.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.3 Mental Health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.00 [9.50, 14.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.4 Emotional role</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.28 [7.96, 12.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.5 Vitality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.75 [6.09, 11.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">UAE versus surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005073.pub4/references#CD005073-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005073.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005073-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005073-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD005073-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005073\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005073\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005073\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005073\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005073\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005073.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005073.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005073.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005073.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005073.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717672003"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005073.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717672013"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005073.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbda38ed0936b',t:'MTc0MDcxNzY3Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 